Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03132961 · ClinicalTrials.gov registry record
Effects of Infrasound Exposure on Measures of Endolymphatic Hydrops
A clinical trial, sponsored by University of Minnesota.
- Terminated
- Registry status
- 12
- Enrollment target
NCT03132961 is a clinical trial that was terminated before completion, run by University of Minnesota. The registered enrollment target is 12 participants.
The verdict
NCT03132961 was terminated before completion, sponsored by University of Minnesota.
- TERMINATED
- Registry status
- 12 participants
- Enrollment target
Study Summary
Persons exposed to infrasound - frequencies below 20 Hz - describe a variety of troubling audiovestibular symptoms, but the underlying mechanisms are not understood. Recent animal studies, however, provide evidence that short-term exposure to low frequency sound induces transient endolymphatic hydrops. The existence of this effect has not been studied in humans. The long-term objective of this research is to identify a possible mechanism to describe the effects of infrasound on the human inner ear. The central hypothesis of the proposed study is that short-term infrasound exposure induces transient endolymphatic hydrops in humans. This will be tested by performing electrophysiologic tests indicative of endolymphatic hydrops among normal hearing individuals before and immediately after a period of infrasound exposure. Recordings of infrasound generated by wind turbines in the field have been established and calibrated by this team of engineers, otologist, and hearing and balance scientists. An infrasound generator reproduces the acoustic signature based on these field recordings. Aim 1: Determine the effect of infrasound on the summating potential to action potential (SP/AP) ratio on electrocochleography (ECoG). Hypothesis 1: Infrasound exposure will cause a reversible elevation of the SP/AP ratio. Aim 2: Determine the effect of infrasound on the threshold response curves of ocular and cervical vestibular evoked myogenic potentials. (oVEMP and cVEMP). Hypothesis 2: Infrasound exposure will cause elevation of the oVEMP and cVEMP thresholds at the frequency of best response. Successful completion of the aims will provide evidence for a possible mechanism of the effect of infrasound on the inner ear. This understanding will benefit individuals exposed to environmental infrasound and those in regulatory, research, and advocacy roles when crafting interventions and future policy.
Interventions
- OTHER Infrasound exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-05-05 |
| Est. Completion | 2018-08-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03132961
The ClinicalTrials.gov registry entry for NCT03132961 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Infrasound exposure is the first listed.
NCT03132961 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03132961 about?
NCT03132961 is a clinical study titled "Effects of Infrasound Exposure on Measures of Endolymphatic Hydrops". Persons exposed to infrasound - frequencies below 20 Hz - describe a variety of troubling audiovestibular symptoms, but the underlying mechanisms are not understood. Recent animal studies, however, provide evidence that short-term exposure to low frequency sound induces transient endolymphatic hydro...
What is the current status of trial NCT03132961?
This trial is currently terminated. The enrollment target is 12 participants. The study started on 2018-05-05. Estimated completion is 2018-08-23.
What interventions are being tested in trial NCT03132961?
The interventions under investigation include: Infrasound exposure (OTHER).
Who is sponsoring clinical trial NCT03132961?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.